England and other nations are on the path toward eliminating hepatitis C. Why not the U.S.?

The world has made great strides in eliminating hepatitis C. But the U.S. remains far behind.

英格兰、埃及、挪威等国通过扩大检测和降低药物门槛，已显著降低丙肝感染与死亡；美国虽有可治愈95%以上患者的药物，新增病例却仍在上升。作者认为，费用、行政障碍与对吸毒者的污名是美国落后的主因，政治意愿是改变的关键。